Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma

Ying Zhu, Jaakko Hollmén, Riikka Räty, Yan Aalto, B. Nagy, Erkki Elonen, Juha Kere, Heikki Mannila, Kaarle Franssila, Sakari Knuutila

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Mantle cell lymphoma (MCL) is a non-Hodgkin's lymphoma of B-cell lineage. The blastoid variant of MCL, characterized by high mitotic rate, is clinically more aggressive than common MCL. We used the cDNA array technology to examine the gene expression profiles of both blastoid variant and common MCL. The data was analysed by regression analysis, principal component analysis and the naive Bayes' classifier. Eight genes were identified as differentially deregulated between the two groups. Oncogenes CMYC, BCL2 and PIM1 were upregulated more frequently in the blastoid variant than in common MCL. This implied that the gp130-mediated signal transducer and activator of transcription 3 (STAT3) signalling pathway was involved in the blastoid variant transformation of MCL. Other differentially deregulated genes were TOP1, CD23, CD45, CD70 and NFATC. By using the eight differentially deregulated genes, we created a classifier to distinguish the blastoid variant from common MCL with high accuracy. We also identified 18 genes that were deregulated in both groups. Among them, BCL1, CALLA/CD10 and GRN were suggested to be oncogenes. The products of RGS1, RGS2, ANX2 and CD44H were suggested to promote tumour metastasis. CD66D was suggested to be a tumour suppressor gene.

Original languageEnglish
Pages (from-to)905-915
Number of pages11
JournalBritish Journal of Haematology
Volume119
Issue number4
DOIs
Publication statusPublished - 2002

Fingerprint

Mantle-Cell Lymphoma
Gene Expression Profiling
Oncogenes
Genes
Cytokine Receptor gp130
STAT3 Transcription Factor
Cell Lineage
Principal Component Analysis
Oligonucleotide Array Sequence Analysis
Tumor Suppressor Genes
Transcriptome
Non-Hodgkin's Lymphoma
B-Lymphocytes
Regression Analysis
Neoplasm Metastasis
Technology

Keywords

  • Array analysis
  • Blastoid variant
  • Differential expression
  • Mantle cell lymphoma

ASJC Scopus subject areas

  • Hematology

Cite this

Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma. / Zhu, Ying; Hollmén, Jaakko; Räty, Riikka; Aalto, Yan; Nagy, B.; Elonen, Erkki; Kere, Juha; Mannila, Heikki; Franssila, Kaarle; Knuutila, Sakari.

In: British Journal of Haematology, Vol. 119, No. 4, 2002, p. 905-915.

Research output: Contribution to journalArticle

Zhu, Y, Hollmén, J, Räty, R, Aalto, Y, Nagy, B, Elonen, E, Kere, J, Mannila, H, Franssila, K & Knuutila, S 2002, 'Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma', British Journal of Haematology, vol. 119, no. 4, pp. 905-915. https://doi.org/10.1046/j.1365-2141.2002.03931.x
Zhu, Ying ; Hollmén, Jaakko ; Räty, Riikka ; Aalto, Yan ; Nagy, B. ; Elonen, Erkki ; Kere, Juha ; Mannila, Heikki ; Franssila, Kaarle ; Knuutila, Sakari. / Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma. In: British Journal of Haematology. 2002 ; Vol. 119, No. 4. pp. 905-915.
@article{c1735f27a37346dcb88f0113b1f314e9,
title = "Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma",
abstract = "Mantle cell lymphoma (MCL) is a non-Hodgkin's lymphoma of B-cell lineage. The blastoid variant of MCL, characterized by high mitotic rate, is clinically more aggressive than common MCL. We used the cDNA array technology to examine the gene expression profiles of both blastoid variant and common MCL. The data was analysed by regression analysis, principal component analysis and the naive Bayes' classifier. Eight genes were identified as differentially deregulated between the two groups. Oncogenes CMYC, BCL2 and PIM1 were upregulated more frequently in the blastoid variant than in common MCL. This implied that the gp130-mediated signal transducer and activator of transcription 3 (STAT3) signalling pathway was involved in the blastoid variant transformation of MCL. Other differentially deregulated genes were TOP1, CD23, CD45, CD70 and NFATC. By using the eight differentially deregulated genes, we created a classifier to distinguish the blastoid variant from common MCL with high accuracy. We also identified 18 genes that were deregulated in both groups. Among them, BCL1, CALLA/CD10 and GRN were suggested to be oncogenes. The products of RGS1, RGS2, ANX2 and CD44H were suggested to promote tumour metastasis. CD66D was suggested to be a tumour suppressor gene.",
keywords = "Array analysis, Blastoid variant, Differential expression, Mantle cell lymphoma",
author = "Ying Zhu and Jaakko Hollm{\'e}n and Riikka R{\"a}ty and Yan Aalto and B. Nagy and Erkki Elonen and Juha Kere and Heikki Mannila and Kaarle Franssila and Sakari Knuutila",
year = "2002",
doi = "10.1046/j.1365-2141.2002.03931.x",
language = "English",
volume = "119",
pages = "905--915",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma

AU - Zhu, Ying

AU - Hollmén, Jaakko

AU - Räty, Riikka

AU - Aalto, Yan

AU - Nagy, B.

AU - Elonen, Erkki

AU - Kere, Juha

AU - Mannila, Heikki

AU - Franssila, Kaarle

AU - Knuutila, Sakari

PY - 2002

Y1 - 2002

N2 - Mantle cell lymphoma (MCL) is a non-Hodgkin's lymphoma of B-cell lineage. The blastoid variant of MCL, characterized by high mitotic rate, is clinically more aggressive than common MCL. We used the cDNA array technology to examine the gene expression profiles of both blastoid variant and common MCL. The data was analysed by regression analysis, principal component analysis and the naive Bayes' classifier. Eight genes were identified as differentially deregulated between the two groups. Oncogenes CMYC, BCL2 and PIM1 were upregulated more frequently in the blastoid variant than in common MCL. This implied that the gp130-mediated signal transducer and activator of transcription 3 (STAT3) signalling pathway was involved in the blastoid variant transformation of MCL. Other differentially deregulated genes were TOP1, CD23, CD45, CD70 and NFATC. By using the eight differentially deregulated genes, we created a classifier to distinguish the blastoid variant from common MCL with high accuracy. We also identified 18 genes that were deregulated in both groups. Among them, BCL1, CALLA/CD10 and GRN were suggested to be oncogenes. The products of RGS1, RGS2, ANX2 and CD44H were suggested to promote tumour metastasis. CD66D was suggested to be a tumour suppressor gene.

AB - Mantle cell lymphoma (MCL) is a non-Hodgkin's lymphoma of B-cell lineage. The blastoid variant of MCL, characterized by high mitotic rate, is clinically more aggressive than common MCL. We used the cDNA array technology to examine the gene expression profiles of both blastoid variant and common MCL. The data was analysed by regression analysis, principal component analysis and the naive Bayes' classifier. Eight genes were identified as differentially deregulated between the two groups. Oncogenes CMYC, BCL2 and PIM1 were upregulated more frequently in the blastoid variant than in common MCL. This implied that the gp130-mediated signal transducer and activator of transcription 3 (STAT3) signalling pathway was involved in the blastoid variant transformation of MCL. Other differentially deregulated genes were TOP1, CD23, CD45, CD70 and NFATC. By using the eight differentially deregulated genes, we created a classifier to distinguish the blastoid variant from common MCL with high accuracy. We also identified 18 genes that were deregulated in both groups. Among them, BCL1, CALLA/CD10 and GRN were suggested to be oncogenes. The products of RGS1, RGS2, ANX2 and CD44H were suggested to promote tumour metastasis. CD66D was suggested to be a tumour suppressor gene.

KW - Array analysis

KW - Blastoid variant

KW - Differential expression

KW - Mantle cell lymphoma

UR - http://www.scopus.com/inward/record.url?scp=18744411789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744411789&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.2002.03931.x

DO - 10.1046/j.1365-2141.2002.03931.x

M3 - Article

C2 - 12472567

AN - SCOPUS:18744411789

VL - 119

SP - 905

EP - 915

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -